TCT-390 AXXESS TREatment for bifurcation coronary disease. A Multicentre rEgistry: first Italian experience. (Estreme-I Registry).

The percutaneous treatment of coronary bifurcation lesions with stent implantation is associated with increased adverse clinical events and inferior angiographic outcomes, when compared with mid-vessel lesions. The Axxess stent is a dedicated, self-expanding, drug-eluting (Biolimus A9) bifurcation